CSP VIATRIS SANTE AT CSP- LAB, — Irbesartan Importer Profile
Pharmaceutical Importer · #4 buyer for Irbesartan · $2.4M import value · 76 shipments · FRANCE · DGFT Verified
CSP VIATRIS SANTE AT CSP- LAB, is the #4 importer of Irbesartan from India with $2.4M in import value and 76 verified shipments. CSP VIATRIS SANTE AT CSP- LAB, holds a 1.7% market share in Irbesartan imports based in FRANCE. The company sources from 1 verified supplier across 34 formulations shipped to 1 country. Overall, CSP VIATRIS SANTE AT CSP- LAB, imports 7 pharmaceutical products worth $10.6M across 5 therapeutic categories.
CSP VIATRIS SANTE AT CSP- LAB, — Irbesartan Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Irbesartan to CSP VIATRIS SANTE AT CSP- LAB,?
Verified from 76 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MYLAN LABORATORIES LIMITED | $2.4M | 76 | 100.0% |
CSP VIATRIS SANTE AT CSP- LAB, sources Irbesartan from 1 verified Indian supplier based on 76 customs records. The primary supplier is MYLAN LABORATORIES LIMITED accounting for 100.0% of imports.
How Does CSP VIATRIS SANTE AT CSP- LAB, Compare to Nearest Irbesartan Importers?
Buyers ranked immediately above and below #4 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | NUEVOS ETICOS NEOETHICALS, S.A. | GUATEMALA | $2.0M | 40 | $50.0K |
| 10 | ARROW GENERIQUES, | FRANCE | $2.0M | 84 | $23.6K |
| 4 | CSP VIATRIS SANTE AT CSP- LAB, ★ | FRANCE | $1.9M | 37 | $50.0K |
| 11 | CSP MYLAN SAS AT CSP LABO 274 | FRANCE | $1.1M | 23 | $50.0K |
| 16 | APOTEX PTY. LTD. | AUSTRALIA | $1.1M | 22 | $49.7K |
CSP VIATRIS SANTE AT CSP- LAB, ranks #4 among 366 Irbesartan importers from India. Average shipment value of $50.0K compared to the market average of $68.3K. The closest competitors by value are NUEVOS ETICOS NEOETHICALS, S.A. and ARROW GENERIQUES,.
Where Does CSP VIATRIS SANTE AT CSP- LAB, Import Irbesartan To?
Destination countries from 76 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $2.4M | 76 | 100.0% |
CSP VIATRIS SANTE AT CSP- LAB, imports Irbesartan to 1 country. The primary destination is FRANCE receiving 100.0% of shipments worth $2.4M.
What Irbesartan Formulations Does CSP VIATRIS SANTE AT CSP- LAB, Import?
| Formulation | Value | Shipments |
|---|---|---|
| IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 3 | $382.9K | 8 |
| IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 1 | $256.5K | 6 |
| HARMLESS MEDICINES, IRBESARTAN / HYDROCH | $115.0K | 3 |
| IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 150MG/12.5MG 90BL TAB (28808 PACKS X 6X15S = 2592720 NOS)NOS | $100.8K | 3 |
| HARMLESS MEDICINES, IRBESARTAN / HYDROCHLOROTHIAZIDE VIATRIS 300MG/25MG 30BL TAB(47605 PACKS)NOS | $99.5K | 3 |
| HARMLESS MEDICINES, IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 150MG/12.5MG 90BL TAB(18464 PACKS)NOS | $63.3K | 3 |
| IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 150MG/12.5MG 90BL TAB (17921 X 90'S)NOS | $62.7K | 3 |
| HARMLESS MEDICINES, IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 300MG/25MG 90BL TAB (9617 PACKS)NOS | $59.1K | 3 |
| HARMLESS MEDICINES, IRBESARTAN / HYDROCHLOROTHIAZIDE VIATRIS 300MG/25MG 30BL TAB(27734 PACKS)NOS | $58.0K | 3 |
| IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 300MG/25MG 90BL TAB (9313 PACKS X 6X15S= 838170 NOS)NOS | $57.4K | 3 |
CSP VIATRIS SANTE AT CSP- LAB, imports 34 distinct Irbesartan formulations from India. The top formulation is IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 3 with 8 shipments worth $382.9K.
Who Are the Top Buyers of Irbesartan from India and How Much Does CSP VIATRIS SANTE AT CSP- LAB, Import?
India exported $25.0M worth of Irbesartan through 2,669 shipments from 123 suppliers to 68 countries, serving 366 buyers globally. CSP VIATRIS SANTE AT CSP- LAB, imports $2.4M of this total, accounting for 1.7% of India's Irbesartan exports with 76 shipments from FRANCE. This is verified from 76 customs shipment records covering 34 distinct formulations.
What Is the Average Order Value for CSP VIATRIS SANTE AT CSP- LAB,'s Irbesartan Imports?
CSP VIATRIS SANTE AT CSP- LAB,'s average Irbesartan order value is $31.5K per consignment, based on 76 shipments totaling $2.4M. CSP VIATRIS SANTE AT CSP- LAB, is based in FRANCE and ranks #4 among all Irbesartan importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Irbesartan to CSP VIATRIS SANTE AT CSP- LAB,?
CSP VIATRIS SANTE AT CSP- LAB, sources Irbesartan from 1 verified Indian supplier: MYLAN LABORATORIES LIMITED ($2.4M, 100.0%). This is based on 76 customs records.
How Does CSP VIATRIS SANTE AT CSP- LAB, Compare to Other Irbesartan Importers?
CSP VIATRIS SANTE AT CSP- LAB, ranks #4 among 366 Irbesartan importers from India with a 1.7% market share. The top 3 importers are MACLEODS PHARMA USA INC ($3.7M), APOTEX PTY LTD. ($2.9M), YUSEN LOGISTICS BENELUX BELGIUM ($2.6M). CSP VIATRIS SANTE AT CSP- LAB, processed 76 shipments from FRANCE.
What Other Cardiovascular Products Does CSP VIATRIS SANTE AT CSP- LAB, Import?
CSP VIATRIS SANTE AT CSP- LAB, also imports these cardiovascular products. Each links to the detailed product page.
About CSP VIATRIS SANTE AT CSP- LAB,
CSP VIATRIS SANTE AT CSP- LAB, imports 7 products worth $10.6M. Beyond Irbesartan, top products include Ramipril, Hydrochlorothiazide, Lansoprazole, Verapamil, Darunavir. View the complete CSP VIATRIS SANTE AT CSP- LAB, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Irbesartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Irbesartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CSP VIATRIS SANTE AT CSP- LAB, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CSP VIATRIS SANTE AT CSP- LAB,'s capped import value divided by total capped export value for Irbesartan across all Indian exporters.
- 5.Verified Records: This page is backed by 76 individual customs records matching CSP VIATRIS SANTE AT CSP- LAB, importing Irbesartan, covering 34 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 68+ countries, 366+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Irbesartan Import Data for CSP VIATRIS SANTE AT CSP- LAB,
Access order-level details, pricing data, supplier connections, and competitive analysis for CSP VIATRIS SANTE AT CSP- LAB,'s Irbesartan imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CSP VIATRIS SANTE AT CSP- LAB,
Full Company Profile →
7 products · $10.6M total trade · 5 categories
CSP VIATRIS SANTE AT CSP- LAB, × Irbesartan
Verified from customs records
Company Overview
Top Products by CSP VIATRIS SANTE AT CSP- LAB,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CSP VIATRIS SANTE AT CSP- LAB,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Irbesartan. For current order-level data, contact TransData Nexus.